amdoxovir has been researched along with mycophenolic acid in 2 studies
| Studies (amdoxovir) | Trials (amdoxovir) | Recent Studies (post-2010) (amdoxovir) | Studies (mycophenolic acid) | Trials (mycophenolic acid) | Recent Studies (post-2010) (mycophenolic acid) |
|---|---|---|---|---|---|
| 33 | 5 | 2 | 9,029 | 1,506 | 3,772 |
| Protein | Taxonomy | amdoxovir (IC50) | mycophenolic acid (IC50) |
|---|---|---|---|
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | 0.1496 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.014 | |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | 0.0772 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.011 | |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borroto-Esoda, K; Feng, J; Furman, P; Jeffrey, J; Myrick, F | 1 |
| Fletcher, CV; Hogg, E; Margolis, DM; Martinez, A; Mellors, JW; Mukherjee, AL; Ogata-Arakaki, D; Petersen, T; Rusin, D | 1 |
1 trial(s) available for amdoxovir and mycophenolic acid
| Article | Year |
|---|---|
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.
Topics: Adult; Aged; Dioxolanes; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Purine Nucleosides; RNA, Viral; Treatment Outcome; Viral Load | 2007 |
1 other study(ies) available for amdoxovir and mycophenolic acid
| Article | Year |
|---|---|
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cell Line; Cloning, Molecular; Dioxolanes; DNA, Mitochondrial; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Enzyme Inhibitors; HIV Protease; HIV-1; Humans; IMP Dehydrogenase; Mycophenolic Acid; Purine Nucleosides; Recombinant Proteins; Ribavirin; RNA, Viral | 2004 |